Navigation Links
Dynasil Corporation of America Reports Fiscal Year 2013 Financial Results
Date:12/20/2013

nce of the new product launches. In fiscal year 2013, these costs and other SG&A costs were substantially reduced while awaiting regulatory approval. 

The Company's updated medical probe, the Navigator 2.0, was approved for sale in May of 2013.
However, as a result of the delays associated with both product line updates and an internal review of strategic alternatives for the lead paint analyzer product, the Company performed an interim impairment test of the Instrument segment and recorded an impairment of goodwill and intangibles totaling $6.8 million in the quarter ending March 31, 2013.

"As reported previously, we are making important steps in right-sizing our business, reducing outstanding indebtedness, and eliminating cost.  With the spin out of our tissue sealant technology to the newly-formed subsidiary, Xcede Technologies, Inc. in October and the divestiture of our XRF product line in November, we continue to make significant improvements to our cash flows and our balance sheet," said Peter Sulick, Chairman and CEO of Dynasil.
"Going forward, we are focused on improving our liquidity and pursuing strategic initiatives that best position the company for future profitable growth."

Including the goodwill impairment charge, net loss for the 12 months ended September 30, 2013 was $8.7 million, or $0.59 per share, compared with a loss of $4.3 million, or $0.29 per share, in fiscal 2012.

Liquidity On December 31, 2012, the Company announced it was in default of certain financial covenants set forth in the terms of its outstanding indebtedness with respect to its fiscal year ended September 30, 2012.
We continued to be in default throughout our fiscal year ended September 30, 2013 and currently remain in default.  As a result, our lenders have the ability to require immediate payment of all indebtedness under our loan agreements.  While the lenders have not exercised this rig
'/>"/>

SOURCE Dynasil Corporation of America
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Dynasil Corporation of America Reports Third Quarter Fiscal 2013 Financial Results
2. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
3. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
4. Richard Wolf Medical Instruments Corporation: 40 Years of Innovation
5. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
6. Luminex Corporation Reports First Quarter 2012 Results
7. ShangPharma Corporation Files 2011 Annual Report on Form 20-F
8. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
9. Without Environmental Hygiene, Hand Hygiene Programs Fall Short in Reducing HAIs in Hospital Settings, Says UMF Corporation
10. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
11. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 17, 2014 Royal Philips ... (NASDAQ: VOLC ), a global leader in catheter-based ... they have entered into a definitive merger agreement. Pursuant to ... all of the issued and outstanding shares of Volcano for ... of USD 1 billion (approx. EUR 800 million), to be ...
(Date:12/17/2014)... , Dec. 17, 2014 With advancements ... the MRI market is seeing new growth, according ... MRI scans account for the majority of market ... resolution of images, which are creating opportunities for more ... market is growing at a rate of 4%, ...
(Date:12/17/2014)... 17, 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... discovering, developing and commercializing innovative therapies addressing major ... of enrollment in its first Phase 2a study, ... confirmed the 1-month findings that were reported in ... - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , , ...
Breaking Medicine Technology:Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
... Boehringer Ingelheim Pharmaceuticals, Inc. announced that new data ... 1 trial show that afatinib (BIBW 2992) reached a ... in progression-free survival (PFS) in advanced non-small cell lung ... growth factor receptor (EGFR) mutation.(1)  The updated LUX-Lung 1 ...
... Clarient, Inc. (Nasdaq: CLRT ), a ... the pharmaceutical industry, today announced the commercial launch of ... the likelihood of recurrence of breast cancer following surgery ... an optimal set of five biomarkers that are able ...
Cached Medicine Technology:New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations 2New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations 3New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations 4New Subgroup Analysis of LUX-Lung 1 Trial Suggests Afatinib Increases Progression-Free Survival in Advanced Lung Cancer Patients More Likely to Have EGFR Mutations 5Clarient Launches Insight® Dx Mammostrat® Breast Cancer Recurrence Test 2Clarient Launches Insight® Dx Mammostrat® Breast Cancer Recurrence Test 3Clarient Launches Insight® Dx Mammostrat® Breast Cancer Recurrence Test 4
(Date:12/21/2014)... 21, 2014 AlignLife of Norton ... while at the same time helping people get their health ... community-based organization committed to serving those persons in Muskegon County ... to improve the quality of life. Dr. Michael Rykse wanted ... in the local community and he knew he found that ...
(Date:12/21/2014)... 2014 Parker & Sons, Inc. a ... plumbing and other similar home contractor services announces a ... to its expert contracting services. The company is considered ... been serving Arizona for well over 40 years. Parker ... best in quality customer service to the residents and ...
(Date:12/21/2014)... 2014 SCI explores disability ... and systemic barriers for disabled athletes with Aaron ... has a condition called juvenile macular degeneration, where he ... he adapted his athletic ambitions to his vision and ... triathlon to pioneer the way for other blind and ...
(Date:12/21/2014)... 21, 2014 As testosterone therapy ... attacks, stroke and blood clots from using testosterone products ... new study shows that the male hormone testosterone may ... a study published in the Proceedings of the National ... examined a group of male rats with naturally occurring ...
(Date:12/21/2014)... The Oncology Institute of Hope and Innovation hosted their ... offices. The Hope for the Holidays Toy Drive is a ... families during the holiday season. This year, the toy drive ... both offices. This event continues to be successful year after ... store managers and assistant managers came out and not only ...
Breaking Medicine News(10 mins):Health News:AlignLife of Norton Shores Makes a Brighter Christmas for Kids in Muskegon 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 2Health News:Parker & Sons Announces Record Number Of Favorable Reviews In 2014 With Regard To Its Expert Contracting Services 3Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4
... RESTON, Va.A new study published in the July issue ... that positron emission tomography (PET) scans in mice can ... breast cancer treatment is working as intended. Researchers successfully ... HER2a protein often associated with aggressive breast cancerin breast ...
... and MYRTLE BEACH, S.C., July 2 Allscripts ... Omega Medical Solutions, a Myrtle Beach, SC-based medical ... Management and Allscripts Payerpath(TM) claims management solution for ... the surrounding states. , , (Logo: ...
... ... challenges for today,s modern woman. Having the right type of support, knowledge, and tools are ... pump technology for working women in decades. The Freemie system is a hands-free and concealable ... , ...
... On Thursday June 18th, 2009, the Association of Organ ... with the 2009 Excellence in Leadership Award. The AOPO ... The national award is presented to an individual who demonstrates ... , Dr. Dan Lebovitz has been actively involved in ...
... ... ... Morehead , the human capital research firm, will host a webinar titled "Preventing ... will be broadcast on Tuesday, July 14, 2009 at 1:00 p.m. EST. , ...
... tobacco tax will increase by $1.00, the biggest of its kind ... part of the Protecting Florida,s Health Act. The pressures of a ... and quit spontaneously. , , New data published in the ... quit attempts are unplanned and these types of attempts can be ...
Cached Medicine News:Health News:Study shows PET can measure effectiveness of novel breast cancer treatment 2Health News:Omega Medical Solutions Selects Allscripts Practice Management and Allscripts Payerpath Revenue Cycle Management 2Health News:Omega Medical Solutions Selects Allscripts Practice Management and Allscripts Payerpath Revenue Cycle Management 3Health News:Omega Medical Solutions Selects Allscripts Practice Management and Allscripts Payerpath Revenue Cycle Management 4Health News:Omega Medical Solutions Selects Allscripts Practice Management and Allscripts Payerpath Revenue Cycle Management 5Health News:Working Moms Find Freedom to Use Breast Pumps Where They Want, When They Want 2Health News:Dr. Dan Lebovitz of Ohio Receives Leadership Award 2Health News:Morehead Presents Webinar on Preventing Physician Disloyalty: Building Stability and Trust with 'At-Risk' Physicians 2Health News:Florida State Tobacco Tax Increase May Prompt Smokers to Quit Spontaneously 2Health News:Florida State Tobacco Tax Increase May Prompt Smokers to Quit Spontaneously 3
... comprehensive line of pregnancy tests including rapid ... convenient one-step stick and cassette formats. The ... Easy HCG is a 25 mIU urine ... HCG II provides 25mIU sensitivity for ...
For the quantitative determination of Glycohemoglobin (HbA1) in blood by,cation exchange resin. The test is to be used to monitor long-term glucose,control in diabetes mellitus....
... isotopic anemia assays feature ... ,pipetting steps for greater ... the processes ,involved in ... benefit to your laboratory ...
... Bio-Rad isotopic anemia ... and minimal ,pipetting steps ... information about the processes ... and the benefit to ...
Medicine Products: